| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.011 | 0.8 |